Search


Novagali Pharma, accessing new eye therapies

Investors

Our Investors

Since its inception in 2000, the firm has raised a total amount of €44 million.

Our investors are : (by alphabetical order)

 

 

1.2.3. Venture

1.2.3. Venture is an independent asset manager dedicated to making private equity available to individual investors through funds of funds, multi-managed funds  

41 boulevard des Capucines
F-75002 Paris
FRANCE
tel: + 33 1 49 26 98 00
fax: + 33 1 49 26 98 19
www.123venture.com

 

Back to top

 

AGF Private Equity

AGF Private Equity, a subsidiary of the AGF Insurance Company, member of the Allianz Group, is specialized in non-listed investments. The company manages an investment portofolio close to €1,7Bn, is among the leaders in France in managing funds of funds, and is also one of the most active investors in Venture Capital. The Venture Capital team has invested in 50 high tech companies. AGF Private Equity is an active partner of growth companies. 

11, rue Scribe
75009 Paris
FRANCE
tel: +33 1 58 18 56 56
fax: +33 1 42 65 56 81
http://www.agfprivatequity.com/

 

Auriga Partners

Auriga Partners is an independent venture capital firm. Based in Paris, it invests in information technologies and life sciences, in innovative high potential ventures, in seed or early development stages, in Europe, North America and Israel. Auriga Partners manages three funds for a total of more than 330 millions euros. Along with investing capital, Auriga Partners brings also its savoir-faire in developing and solidifying executive teams, organizing companies, broadening their networks and forming strategic and corporate partnerships. 

18 avenue Matignon
F-75008 Paris
FRANCE
tel: + 33 1 53 30 07 07
fax: + 33 1 53 30 07 00
http://www.aurigapartners.com

 

Back to top

 

CDC Innovation

Founded in 1996, CDC Innovation is an international venture capital firm with its head office in Paris and a local presence in the Silicon Valley and in Switzerland. With over 415 M€ currently under management, our focus is on venture investments at both the early and late stage, in two sectors: information technologies and life sciences.
Our aim is to create value by providing talented entrepreneurs with the resources, experience, and network necessary to turn world-class technologies into great businesses.

63 av. des Champs Elysees Paris 75008
FRANCE
tel: +33 1 58 50 71 71
fax: +33 1 40 64 27 72

www.cdcentreprises.fr

CDC

 

Crédit Agricole Private Equity

Crédit Agricole Private Equity is an AMF-accredited asset management subsidiary of Crédit Agricole S.A., specialising in private equity investment in unlisted companies. A team of 40 professionals operating in five areas (Later-Stage Financing & LBO, Venture Capital, Secondary Market, Mezzanine, Renewable Energies, PPP Infrastructures, Liquidity solutions), manages €1.5 billion through venture and innovation funds. Crédit Agricole Private Equity provides advice and support for business managers implementing growth plans. 

4 place Raoul-Dautry
tsa 60101
F-75730 Paris cedex 15
FRANCE
tel: + 33 1 40 23 09 93
http://www.privatequity.creditlyonnais.com/

 

Back to top

 

Edmond de Rothschild Investment Partners

Paris based Edmond de Rothschild Investment Partners (EDRIP) is dedicated to minority investments into privately-owned companies. It has currently more than 500 million under management which are being invested primarily as life sciences venture capital and growth capital. EdRIP is part of the group La Compagnie Financière Edmond de Rothschild.

EdRIPs Life Science Team of 6 professionals has over 80 years of cumulated experience in the life science industry and already a proven track record in Biotech and Medtech investments. The team has approximately 150 million under management after having recently raised 100 million through BioDiscovery II and related funds to be invested during the next 2 years, mainly in the EU.

47 rue du Faubourg Saint-Honoré
F-75401 Paris cedex 08
FRANCE
tel: + 33 1 40 17 25 25
www.edrip.fr

 

FCJE (Co-Investment Funds for Young Enterprises)

4CDC Entreprises Innovation, FP Gestion

33 Avenue du Maine
BP 174
F-75755 Paris cedex 15
FRANCE
tel: +33 1 58 50 71 75
fax: +33 1 58 50 07 75
www.fpgestion.fr

 

Back to top

 

Siparex Ventures

The venture capital activity accounts for 19% of SIGEFI PRIVATE EQUITY / SIPAREX GROUP (€850 million) assets under management. SIGEFI PRIVATE EQUITY is one of the leading private equity investors in France. The “Group” first entered the venture capital business in the United States, where it has been present for 20 years through its San Francisco office. In France, specialized funds finance start-ups, mainly in the sectors of information technology and the life sciences. Siparex Ventures manages 12 early stage funds. Siparex Ventures’ team comprises 10 professionals based in Lyon and Paris.
For more information : www.siparex.com
 

139 rue Vendôme
F-69006 Lyon
FRANCE
tel: +33 4 72 83 23 23
fax: +33 4 72 83 23 00
www.siparex.com



Choose your language